The concept of risk and the value of novel markers of acute kidney injury

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Ronco, Claudio ^a   Ricci, Zaccaria ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; HUMAN; INTENSIVE CARE; NOTE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK FACTOR;

EID: 84873623050     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12488     Document Type: Note

References (8)

1. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007, 18:1292-1298. 10.1681/ASN.2006070756, 17314324.
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
3. Kellum JA, Bellomo R, Ronco C. Kidney attack. JAMA 2012, 307:2265-2266.
4. Kidney Disease: Improving Global Outcomes Clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012, 2:89-115. Kidney Disease: Improving Global Outcomes.
5. Goldstein SL, Chawla LS. Renal angina. Clin J Am Soc Nephrol 2010, 5:943-949. 10.2215/CJN.07201009, 20299370.
6. Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care 2012, 16:313. 10.1186/cc10920, 22721504.
7. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MNG, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EAJ, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmele R, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013, 17:R25. 10.1186/cc12503, 23388612.
8. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, et al. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 2012, 7:844-850. 10.2215/CJN.12791211, 22442182.